OWC Pharmaceutical Research Corp (OWCP)

[skitahoe]

The retrenchment this morning is something I believe is healthy, nothing only goes up forever. We'll see if we get a positive close today, and for the year tomorrow.

As for the gap at $.435, any positive news would probably assure that that gap will never fill, however if we have no news in January, I wouldn't be surprised to see it fill before the end of the month. As you know, at the end of the month I'm planning to buy back the shares I sold for a tax loss, and probably add a little beyond that, I certainly wouldn't mind paying essentially what I sold the shares for, but will be profitable on the my shares if I pay more.

January certainly should have gains for cannabis in general with several major markets opening, however right now the effect on OWCP is only what it will see by association with cannabis as it currently isn't selling product in any market. I would hope that by the Wall Street Conference the company clarifies when and where they expect the first sales of the cream to occur, but it is by no mean certain if they don't have safety trial results by then.

If the goals scheduled to occur in the latest guidance do occur on schedule, OWCP should be a very different company by the end of each quarter next year and depending on when sales begin might easily have a market cap in the billions by the end of the year. Ultimately it will be revenue that drives the market cap, but just the fact that it does have sales will give it tremendous credibility for following its business plan.

Happy New Year's all,

Gary